New surgical technique for bladder tumors shows promise in small study
NCT ID NCT07259798
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compared two surgical methods for removing medium-sized bladder tumors (2-6 cm) in 50 patients. One method removes the tumor in one piece (en-bloc), while the other removes it in fragments (conventional). The goal was to see which method provides better tissue samples for diagnosis and potentially better outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If en-bloc resection proves better, it could become the preferred surgical technique for removing medium-sized bladder tumors, improving diagnosis and reducing recurrence.
- What could go wrong
- This is a small, completed study with only 50 participants, so results may not apply to all patients. The comparison is about surgical technique, not a new treatment, so impact is limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for URINARY BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University
Cairo, Abbasia, 11566, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could an ALS drug clear the fog of chemo brain?
- Promising combo aims to shrink bladder tumors before surgery
- Engineered immune cells take aim at multiple cancers in early trial
- Bladder cancer patients may skip surgery with new drug combo
- New program aims to protect cancer Patients' hearts during treatment
- MRNA cancer shots: new hope or hype?